Two Illinois brothers indicted for a $300 million COVID-19 testing fraud targeting Medicare, Medicaid, and private insurers with health care fraud and money laundering charges.
Medicare Part D stand-alone drug plans decline as enrollment in Medicare Advantage with drug coverage rises, reshaping market options for 2026.
The Medicare-X Choice Act aims to create a public health insurance option nation-wide, enhancing affordability, coverage, and competition amid Medicaid cuts and ACA tax credit expirations.
The Medicare Diabetes Prevention Program has enrolled less than 1% of eligible beneficiaries since 2018 due to administrative, referral, and awareness challenges despite proven effectiveness. CMS changes aim to improve access and provider reimbursement.
Medicare's outdated reimbursement system is jeopardizing rural office-based medical practices by underpaying for advanced outpatient procedures, leading to consolidation and increased healthcare costs. Proposed reforms aim to preserve independent care and improve access.
CMS expands Medicare drug price controls to 25 medications, achieving $12 billion savings with new Maximum Fair Prices starting 2026 and 2027 for chronic and cancer treatments.
CMS has proposed key 2027 updates to Medicare Advantage and Part D Star Ratings aiming to streamline quality measures and modernize enrollment options to enhance care and plan accountability.
Kinney Drugs teams with EnlivenHealth to provide free Medicare Part D plan comparisons aiding seniors during Medicare open enrollment. Learn about plan options and enrollment strategies.
Medicare’s 2025 open enrollment period ends December 7. Learn key details on plan options, enrollment processes, and compliance for insurance professionals.
HHS-OIG audit uncovers $39.6 million in potentially improper podiatry E/M payments, urging CMS to enhance Medicare oversight in billing practices.
